Pre-analytical stability of the CEA, CYFRA 21.1, NSE, CA125 and HE4 tumor markers.

Canki, Esra; Schuurbiers, Milou Mf; Linders, Theodora C; Korse, Catharina M; van den Heuvel, Michel M; van Herwaarden, Antonius E; van Rossum, Huub H

Canki, Esra; Schuurbiers, Milou Mf; Linders, Theodora C; Korse, Catharina M; van den Heuvel, Michel M; van Herwaarden, Antonius E; van Rossum, Huub H.

Afiliación

Canki E; Department of Laboratory Medicine, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Schuurbiers MM; Department of Respiratory Diseases, Radboud Medical Center, Nijmegen, The Netherlands.
Linders TC; Department of Respiratory Diseases, Radboud Medical Center, Nijmegen, The Netherlands.
Korse CM; Department of Laboratory Medicine, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
van den Heuvel MM; Department of Laboratory Medicine, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
van Herwaarden AE; Department of Respiratory Diseases, Radboud Medical Center, Nijmegen, The Netherlands.
van Rossum HH; Department of Laboratory Medicine, Radboud Medical Center, Nijmegen, The Netherlands.

Tumour Biol ; 46(s1): S15-S25, 2024.

Article en En | MEDLINE | ID: mdl-37302060

Asunto(s)

Biomarcadores de Tumor; Neoplasias Pulmonares; Humanos; Antígeno Carcinoembrionario; Antígenos de Neoplasias; Queratina-19; Neoplasias Pulmonares/patología

Palabras clave

CA125; CEA; CYFRA 21.1; HE4; NSE; Pre-analytical stability; serum; tumor marker

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Biomarcadores de Tumor / Neoplasias Pulmonares Tipo de estudio: Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: Tumour Biol Asunto de la revista: NEOPLASIAS Año: 2024 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google